SHANNON SNYDER: Open Payments
NPI 1164668448 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 80 payments from 19 companies in 2025. Trend: 2023 $1,862 · 2024 $2,809 · 2025 $2,266
Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 13 | $346 |
| AstraZeneca Pharmaceuticals LP | 11 | $310 |
| GENZYME CORPORATION | 7 | $264 |
| Regeneron Healthcare Solutions, Inc. | 9 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $222 |
| PFIZER INC. | 8 | $165 |
| Genentech USA, Inc. | 2 | $127 |
| Novo Nordisk Inc | 1 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Optinose US, Inc. | 3 | $81 |
Products named: DUPIXENT, AIRSUPRA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Hizentra, Xolair, Andembry, HYQVIA, Ozempic.
Industry payments across FL — which companies pay providers there.
